PEDRO
PÉREZ SEGURA
Profesor asociado de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (177)
2024
-
A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma
Journal of Neuro-Oncology, Vol. 166, Núm. 3, pp. 407-415
-
Comprehensive splicing analysis of the alternatively spliced CHEK2 exons 8 and 10 reveals three enhancer/silencer-rich regions and 38 spliceogenic variants
Journal of Pathology, Vol. 262, Núm. 4, pp. 395-409
-
Correction to: A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma (Journal of Neuro-Oncology, (2024), 166, 3, (407-415), 10.1007/s11060-023-04513-1)
Journal of Neuro-Oncology
-
Exploring gastric cancer genetics: A turning point in common variable immunodeficiency
Journal of Allergy and Clinical Immunology: Global, Vol. 3, Núm. 2
-
Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2
International Journal of Molecular Sciences, Vol. 25, Núm. 4
-
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain
Clinical and Translational Oncology
-
Major and durable responses to photon and electron-beam palliative radiotherapies after immune-checkpoint inhibitors in head and neck cancer
Oral Oncology
-
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site Variants
Clinical chemistry, Vol. 70, Núm. 1, pp. 319-338
2023
-
Clinical Behavior, Mutational Profile and T-Cell Repertoire of High-Grade Neuroendocrine Tumors of the Head and Neck
Cancers, Vol. 15, Núm. 9
-
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned
Journal of Hematology and Oncology, Vol. 16, Núm. 1
-
Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome
Anais Brasileiros de Dermatologia, Vol. 98, Núm. 5, pp. 696-698
-
Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer
Anti-Cancer Drugs, Vol. 34, Núm. 5, pp. 695-698
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
Cancers, Vol. 15, Núm. 12
-
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581
-
Prognostic value of human leukocyte antigen G expression in solid tumors: a systematic review and meta-analysis
Frontiers in Immunology, Vol. 14
-
Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors
International Journal of Molecular Sciences, Vol. 24, Núm. 14
-
Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer
Oncology Letters, Vol. 25, Núm. 1
-
Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors
Biomedicines, Vol. 11, Núm. 4
-
Specific Cellular and Humoral Response after the Third Dose of Anti-SARS-CoV-2 RNA Vaccine in Patients with Immune-Mediated Rheumatic Diseases on Immunosuppressive Therapy
Biomedicines, Vol. 11, Núm. 9